Gossamer Bio (GOSS) EBT Margin (2024 - 2026)
Gossamer Bio (GOSS) posted quarterly EBT Margin of 295.38% for Q1 2026, up 10165.0% year-over-year from N/an in Q1 2025, and up 13.87% quarter-over-quarter from 342.97% in Q4 2025.
Gossamer Bio (GOSS) EBT Margin (2024 - 2026) Analysis & Trends
Gossamer Bio's EBT Margin history runs 3 years deep, the most recent figure standing at 295.38% for Q1 2026.
- In Q1 2026, EBT Margin rose 10165.0% year-over-year to 295.38%; the TTM figure through Mar 2026 stood at 331.13% (down 27848.0% YoY), while the FY2025 annual figure was 351.67%, down 29033.0% from the prior year.
- EBT Margin for Q1 2026 stood at 295.38%, up from 342.97% in the prior quarter.
- The five-year high for EBT Margin was 242.37% in Q4 2024, with the low at 397.03% in Q1 2025.
- The 3-year median for EBT Margin is 335.0% (2024), against an average of 221.22%.
- The sharpest annual moves came in 2025 and 2026: EBT Margin plunged 58533 bps in 2025, then surged 10165 bps in 2026.
- Gossamer Bio's EBT Margin stood at 242.37% in 2024, then plunged by 242 bps to 342.97% in 2025, then gained by 14 bps to 295.38% in 2026.
- Business Quant data shows GOSS's EBT Margin at 295.38% in Q1 2026, 342.97% in Q4 2025, and 362.73% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | Gossamer Bio | 50.34 Mn | -6.69 Mn | - | -308.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -331.08% |
| Mar 31, 2026 | -295.38% |
| Dec 31, 2025 | -342.97% |
| Sep 30, 2025 | -362.73% |
| Jun 30, 2025 | -333.13% |
| Mar 31, 2025 | -397.03% |
| Dec 31, 2024 | 242.37% |
| Sep 30, 2024 | -336.87% |
| Jun 30, 2024 | 56.00% |